Search results
BofA lifts Novo Nordisk price target on EPS upside potential, upcoming pipeline data By...
Investing.com· 12 hours agoBank of America lifted its target price on Novo Nordisk’s (NVO) Denmark-listed shares to DKK 1,150...
Argus ups Novo Nordisk shares target on strong pipeline and growth outlook By Investing.com
Investing.com· 5 days agoThe Denmark...robust pipeline of new products, which includes Phase 3 candidates like new...
Why Home-Builder Stocks Can Continue Their Bull Run
Barrons.com· 8 hours agoHome inventory is up, but still very low and prices remain high. That means builder profits should remain fat. Plus, exploiting the rush to obesity...
Ozempic, Wegovy May Protect Kidney Health, New Research Finds
Health.com· 4 days agoOzempic and Wegovy are used to treat type 2 diabetes and obesity, respectively, but they may also be...
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Motley Fool via Yahoo Finance· 15 hours agoAnd that doesn't even account for the fact that the need for such procedures will increase as the...
Use of weight loss and diabetes drugs like Ozempic has skyrocketed in Mass.
WBUR Boston· 1 day agoThe number of Massachusetts residents prescribed a relatively new class of drugs used for diabetes...
Making the case for Wegovy coverage: Drug keeps weight off for 4 years, aids heart health
BenefitsPRO· 3 days agoDrugmaker Novo Nordisk has released two new trial results that could strengthen the case for...
Anti-obesity drugs will be 2024’s defining trend
Pharmaceutical Technology via Yahoo Finance· 3 days agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence, and cell and gene therapies.
Ozempic, Wegovy, Mounjaro popularity soar as weight loss wonders
Pittsburgh Tribune-Review· 2 days agoFor Diane Lang, the big push to focus on her health and weight came from her grandchildren. Lang, of...
Sanders calls vote to subpoena Novo Nordisk president
Becker’s Hospital Review· 4 days agoFollowing jousts between Vermont Sen. Bernie Sanders and Novo Nordisk, the Senate Committee on Health, Education, Labor, and Pensions will vote June 18 on whether to subpoena the drugmaker's ...
